These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1578480)

  • 41. Evidence for specific analgesic activity of a muscarinic agonist selected among a new series of acetylenic derivatives.
    Barocelli E; Ballabeni V; Bertoni S; De Amici M; Impicciatore M
    Life Sci; 2001 Mar; 68(15):1775-85. PubMed ID: 11270624
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distinct muscarinic receptor subtypes differentially modulate acetylcholine release from corticocerebral synaptosomes.
    Pittel Z; Heldman E; Rubinstein R; Cohen S
    J Neurochem; 1990 Aug; 55(2):665-72. PubMed ID: 1695243
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential regulation of subtypes m1-m5 of muscarinic receptors in forebrain by chronic atropine administration.
    Wall SJ; Yasuda RP; Li M; Ciesla W; Wolfe BB
    J Pharmacol Exp Ther; 1992 Aug; 262(2):584-8. PubMed ID: 1323653
    [TBL] [Abstract][Full Text] [Related]  

  • 44. alpha-Methyl analogues of acetylenic amines as striatal muscarinic antagonists.
    Sethy VH; Heier RF; Moon MW
    J Pharm Pharmacol; 1991 Sep; 43(9):670-1. PubMed ID: 1685530
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
    Ehlert FJ; Jenden DJ
    Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Autoradiographic analyses of agonist binding to muscarinic receptor subtypes.
    Messer WS; Ellerbrock B; Price M; Hoss W
    Biochem Pharmacol; 1989 Mar; 38(5):837-50. PubMed ID: 2564779
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Ichikawa J; Chung YC; Li Z; Dai J; Meltzer HY
    Brain Res; 2002 Dec; 958(1):176-84. PubMed ID: 12468043
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bretylium tosylate binds preferentially to muscarinic receptors labelled with [3H]oxotremorine M (SH or 'high affinity' receptors) in rat heart and brain cortex.
    Gillard M; Brunner F; Waelbroeck M; Svoboda M; Christophe J
    Eur J Pharmacol; 1989 Jan; 160(1):117-24. PubMed ID: 2714357
    [TBL] [Abstract][Full Text] [Related]  

  • 49. On the involvement of multiple muscarinic receptor subtypes in the activation of phosphoinositide metabolism in rat cerebral cortex.
    Forray C; el-Fakahany EE
    Mol Pharmacol; 1990 Jun; 37(6):893-902. PubMed ID: 2163015
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Muscarinic suppression of the evoked N-wave by oxotremorine-M recorded in the guinea-pig olfactory cortex slice.
    Bagetta G; Constanti A
    Eur J Pharmacol; 1990 Mar; 178(1):91-6. PubMed ID: 2332031
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Muscarinic receptor binding profile of para-substituted caramiphen analogues.
    Hudkins RL; DeHaven-Hudkins DL; Stubbins JF
    J Med Chem; 1991 Oct; 34(10):2984-9. PubMed ID: 1920350
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Muscarinic actions and receptor binding of the enantiomers of BM 130, an alkylating analog of oxotremorine.
    Ringdahl B; Katz ED; Roch M; Jenden DJ
    J Pharmacol Exp Ther; 1989 Apr; 249(1):210-5. PubMed ID: 2709331
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Age-related differences in the effects of some muscarinic agents on acetylcholine release from rat neostriatal slices.
    Lee HJ; Cozzi NV; Weiler MH
    J Pharmacol Exp Ther; 1991 Aug; 258(2):496-501. PubMed ID: 1865353
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sialic acid residues as catalysts for M2-muscarinic agonist-receptor interactions.
    Haddad EB; Landry Y; Gies JP
    Mol Pharmacol; 1990 May; 37(5):682-8. PubMed ID: 1692606
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacologic characterization and functional role of muscarinic autoreceptors in the rabbit striatum.
    James MK; Cubeddu LX
    J Pharmacol Exp Ther; 1987 Jan; 240(1):203-15. PubMed ID: 3806384
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changes in rat brain muscarinic receptors after inhibitory avoidance learning.
    Ortega A; del Guante MA; Prado-Alcalá RA; Alemán V
    Life Sci; 1996; 58(9):799-809. PubMed ID: 8632727
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heterogeneity of presynaptic muscarinic receptors regulating neurotransmitter release in the rat brain.
    Raiteri M; Leardi R; Marchi M
    J Pharmacol Exp Ther; 1984 Jan; 228(1):209-14. PubMed ID: 6141277
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Binding sites for [3H]AF-DX 116 and effect of AF-DX 116 on endogenous acetylcholine release from rat brain slices.
    Lapchak PA; Araujo DM; Quirion R; Collier B
    Brain Res; 1989 Sep; 496(1-2):285-94. PubMed ID: 2804636
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Binding and functional selectivity of himbacine for cloned and neuronal muscarinic receptors.
    Miller JH; Aagaard PJ; Gibson VA; McKinney M
    J Pharmacol Exp Ther; 1992 Nov; 263(2):663-7. PubMed ID: 1331410
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Muscarinic M1 receptors stimulate phosphoinositide hydrolysis in bovine cerebral arteries.
    Garcia-Villalon AL; Ehlert FJ; Krause DN; Duckles SP
    Life Sci; 1990; 47(23):2163-9. PubMed ID: 2176261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.